AzTrials
AzTrials

Surgery--ComplicationsVFC COLORECTALNCT04367987

Variability of Heart Rate as a Marker of Complication of Colorectal Surgery

An observational study of Surgery--Complications, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Heart rate variability reflects the autonomic nervous system on the intrinsic activity of sinus node cells. Sympathetic hyperactivity is an adaptation to stress, while parasympathetic hyperactivity is present at rest. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Surgery--Complications
What is being tested?
Heart Rate Variability
How many people
117 participants
Where
1 siteFrance
Study dates
17 Jun 2020to Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All patients undergoing scheduled colorectal resection or operated on in the digestive surgery department of the CHU Nîmes

Who may be able to join

  • Patients operated for a scheduled colorectal resection due to cancer, diverticulitis, or Chronic Inflammatory Bowel Disease,
  • American Society of Anesthesiologists score 1-2
  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan

Who cannot join

  • Patient taking antidepressants, antipsychotics, antihypertensive beta blocker type, anti-arythmic or oral contraception
  • Uncontrolled diabetes or associated with a neuropathy
  • Arrhythmias and conduction disturbances, , coronaropathy and heart failure, kidney failure
  • Neuropathies
  • Pacemaker or defibrillator
  • The subject is participating in another interventional study, or is in a period of exclusion determined by a previous study
Show all 9Show fewer
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • CHU de Nimes

    Nîmes

    Anissa Megzari, 04.66.68.42.36, drc@chu-nimes.fr

    Martin Bertrand

    Recruiting

Other trials in France

About this study

Heart rate variability reflects the autonomic nervous system on the intrinsic activity of sinus node cells. Sympathetic hyperactivity is an adaptation to stress, while parasympathetic hyperactivity is present at rest. Thus, any variability in the heart frequency rate reflects variations in sympathetic and parasympathetic components in the autonomic nervous system. Failure to return to normal or a reduction in the variability of the heart rate in the postoperative period is correlated with complications in colorectal surgery.

Being tested
Heart Rate Variability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heart Rate VariabilityDiagnostic test

    Heart rate and RR interval Post-anonymized analysis of heart rate variability using the KUBIOS software

Study groups in NCT04367987
Study groupRoleWhat they receive
Patients undergoing colorectal surgeryNot described
Receives: Diagnostic Test: Heart Rate Variability

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of variability of the heart rate between Day-1 to Day 7

    Measured by power spectral density; ratio of the high to low frequencies

    Measured: Day 7

  2. Correlation between the rate of variability of the heart rate between Day-1 to Day 7and anastomotic fistula diagnosed according to Center for Diseases Control criteria after scheduled colorectal surgery

    Abdominal-pelvic imagery

    Measured: Hospital discharge (maximum Day 7)

  3. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and peri-anastomotic fluid collections after scheduled colorectal surgery

    Abdominal-pelvic imagery

    Measured: Hospital discharge (maximum Day 7)

Secondary outcomes (12)
  1. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of intra abdominal abscess

    diagnosed on CT-scan

    Measured: Hospital discharge (maximum Day 7)

  2. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of gut wall abscess

    Measured: Hospital discharge (maximum Day 7)

  3. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of pneumonia

    Measured: Hospital discharge (maximum Day 7)

  4. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of urinary tract infection

    Measured: Hospital discharge (maximum Day 7)

  5. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of central venous catheter infection

    Measured: Hospital discharge (maximum Day 7)

  6. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of intra abdominal hematoma

    Measured: Hospital discharge (maximum Day 7)

  7. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of hemorrhagic shock

    Measured: Hospital discharge (maximum Day 7)

  8. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and death rate

    Measured: Hospital discharge (maximum Day 7)

  9. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of deep vein thrombosis

    Measured: Hospital discharge (maximum Day 7)

  10. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of pulmonary embolism

    Measured: Hospital discharge (maximum Day 7)

  11. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of acute pulmonary edema

    Measured: Hospital discharge (maximum Day 7)

  12. Correlation between the rate of variability of the heart rate between Day-1 to Day 7 and presence of heart disease

    Measured: Hospital discharge (maximum Day 7)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2020
  2. Study start17 Jun 2020
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
117 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04367987
Sponsor's protocol ID
Local/2018/MB-01
Acronym
VFC COLORECTAL
Status last verified
Jun 2026
First submitted
27 Apr 2020
Last updated
16 Jun 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Surgery--Complications, run by Centre Hospitalier Universitaire de Nīmes at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Martin Bertrand (04.66.68.68.09, martin.bertrand@chu-nimes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of variability of the heart rate between Day-1 to Day 7 (time frame: Day 7). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in